A Retrospective Study of the Navio Robotic-assisted Surgical System
NAVIO
1 other identifier
observational
128
1 country
5
Brief Summary
A retrospective, multi-center, cohort study with prospective follow-up and comparison to historical control
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2017
Shorter than P25 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2017
CompletedFirst Posted
Study publicly available on registry
March 7, 2017
CompletedStudy Start
First participant enrolled
July 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 29, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 29, 2017
CompletedResults Posted
Study results publicly available
May 2, 2022
CompletedMay 25, 2022
December 1, 2021
5 months
March 2, 2017
July 1, 2019
May 2, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluate the Navio™ System for Revisions at 2+ Years Post-surgical Implantation Survivorship
Analysis of the absence of device revision (overall survivorship) outcomes assessed from Baseline through 120 weeks post-surgical implantation.
Preoperative (Baseline) and 24, 48, 72, 96, and 120 weeks postoperatively
Secondary Outcomes (9)
Evaluation of Efficacy Based on Knee Society Score (KSS) Assessments
Preoperative (Baseline) and 6, 12, 18, 24, 30, and 36 months postoperatively
Evaluation of Efficacy Based on Veterans RAND 12 (VR-12) Assessments
Preoperative (Baseline) and 6, 12, 18, 24, 30, and 36 months postoperatively
Preoperative Evaluation of Efficacy Based on Radiographic Findings
Preoperative (Baseline)
Postoperative 6-Month Evaluation of Efficacy Based on Radiographic Findings
6 months postoperatively
Postoperative 12-Month Evaluation of Efficacy Based on Radiographic Findings
12 months postoperatively
- +4 more secondary outcomes
Eligibility Criteria
One hundred twenty-eight (128) subjects, including 10% inflation to allow for attrition
You may qualify if:
- Male or female subjects ≥ 18 years old (at the time of surgery) who have undergone Navio System-assisted UKR at least 2 years prior to enrollment. This includes UKR procedures with all Unicondylar Knee cemented implant designs.
- Subject had a primary diagnosis of unicompartmental, non-inflammatory degenerative joint disease including osteoarthritis, traumatic arthritis, or avascular necrosis, required correction of functional deformity, or required treatment of fractures that were unmanageable using other techniques.
You may not qualify if:
- Subject received the Navio System-assisted UKR on the index joint as a revision for a previously failed UKR.
- Subject, in the opinion of the Investigator, had advanced osteoarthritis or joint disease at the time of surgery and was better suited for Total Knee Arthroplasty (TKA).
- Subject, in the opinion of the Investigator, had a neuromuscular disorder that prohibited control of the index joint.
- Subject, in the opinion of the Investigator, was morbidly obese.
- Subject, in the opinion of the Investigator, was contraindicated for UKR.
- Subject (prospective subjects only), in the opinion of the Investigator, has an emotional or neurological condition including mental illness, mental retardation, drug or alcohol abuse.
- Subject (prospective subjects only) is a prisoner.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Hedley Orthopedics
Phoenix, Arizona, 85016, United States
Santa Barbara Cottage Hospital
Santa Barbara, California, 93105, United States
Bronson Orthopedic Specialists
Battle Creek, Michigan, 49015, United States
OrthoNeuro New Albany
New Albany, Ohio, 43054, United States
Rothman Institute
Philadelphia, Pennsylvania, 19107, United States
Limitations and Caveats
There were no known study limitations.
Results Point of Contact
- Title
- Salima Reddy
- Organization
- Smith & Nephew, Inc.
Study Officials
- STUDY DIRECTOR
Beate Hanson, MD, PhD
Smith & Nephew, Inc.
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2017
First Posted
March 7, 2017
Study Start
July 10, 2017
Primary Completion
November 29, 2017
Study Completion
November 29, 2017
Last Updated
May 25, 2022
Results First Posted
May 2, 2022
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share